China biopharma development still hot & still expanding its reach

Retrieved on: 2025-01-21 08:14:40

Tags for this article:

Novartis

JIANGSU HENGRUI

Merck & Co.

China

United States

Click the tags to see associated articles and topics

China biopharma development still hot & still expanding its reach. View article details on hiswai:

Summary

The article highlights China's growing role in the global biopharma industry, with companies like Jiangsu Hengrui, Novartis, and Merck & Co. engaging in cross-border deals. Collaborative efforts continue despite US-China tensions, reflecting China's increasing innovation and investment in R&D.

Article found on: www.bioxconomy.com

View Original Article